JPH0377461B2 - - Google Patents

Info

Publication number
JPH0377461B2
JPH0377461B2 JP57126527A JP12652782A JPH0377461B2 JP H0377461 B2 JPH0377461 B2 JP H0377461B2 JP 57126527 A JP57126527 A JP 57126527A JP 12652782 A JP12652782 A JP 12652782A JP H0377461 B2 JPH0377461 B2 JP H0377461B2
Authority
JP
Japan
Prior art keywords
red blood
agglutination
cell membrane
blood cells
aqueous solvent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP57126527A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5915859A (ja
Inventor
Yatsuhiro Kamimura
Masakazu Tajima
Shozo Ishii
Satoru Funakoshi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GC Biopharma Corp
Original Assignee
Green Cross Corp Korea
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Green Cross Corp Korea filed Critical Green Cross Corp Korea
Priority to JP12652782A priority Critical patent/JPS5915859A/ja
Publication of JPS5915859A publication Critical patent/JPS5915859A/ja
Publication of JPH0377461B2 publication Critical patent/JPH0377461B2/ja
Granted legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/554—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being a biological cell or cell fragment, e.g. bacteria, yeast cells
    • G01N33/555—Red blood cell

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP12652782A 1982-07-19 1982-07-19 凝集試験用水性溶媒 Granted JPS5915859A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP12652782A JPS5915859A (ja) 1982-07-19 1982-07-19 凝集試験用水性溶媒

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP12652782A JPS5915859A (ja) 1982-07-19 1982-07-19 凝集試験用水性溶媒

Publications (2)

Publication Number Publication Date
JPS5915859A JPS5915859A (ja) 1984-01-26
JPH0377461B2 true JPH0377461B2 (en, 2012) 1991-12-10

Family

ID=14937406

Family Applications (1)

Application Number Title Priority Date Filing Date
JP12652782A Granted JPS5915859A (ja) 1982-07-19 1982-07-19 凝集試験用水性溶媒

Country Status (1)

Country Link
JP (1) JPS5915859A (en, 2012)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0954091A (ja) * 1995-08-09 1997-02-25 Nippon Zoki Pharmaceut Co Ltd 抗赤血球抗体の測定法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5523402A (en) * 1978-03-24 1980-02-19 Yatoron:Kk Manufacture of reagent for indirect red corpuscle agglutination which absorbs simultaneously heterogenetic antibody

Also Published As

Publication number Publication date
JPS5915859A (ja) 1984-01-26

Similar Documents

Publication Publication Date Title
EP0019741B1 (de) Latex-Reagenz, Verfahren zu seiner Herstellung, seine Verwendung und ein das Reagenz enthaltendes Mittel
EP0064274B1 (en) Method for assaying antigen-antibody reactions and reagent therefor
US4060597A (en) Serological reagent and preparation thereof
Cayzer et al. An evaluation of two new haemagglutination tests for the rapid diagnosis of autoimmune thyroid diseases.
CA1168580A (en) Immunological reagent for the detection of tubes of the rheumatoid factor in a biological specimen and process for preparing this novel reagent
US5318913A (en) Reagent for the determination by hemagglutination of antibodies to bacterial toxins, method of preparation and application thereof
US5494800A (en) Analyte detection in particulate-containing samples
JPS6022295B2 (ja) 赤血球凝集試験用水性溶媒
EP0554657B1 (de) Verfahren zur Bestimmung von Antigenen oder Antikörpern in Gegenwart eines Immunkomplexes
JPH0377461B2 (en, 2012)
JP2000193663A (ja) ヒトｄ―ダイマ―測定試薬キット
JPS59102161A (ja) 逆受身凝集反応による抗原検出用試薬
JP3618797B2 (ja) 免疫測定法
JPH0456258B2 (en, 2012)
JPS6229746B2 (en, 2012)
JPS638426B2 (en, 2012)
JPH08327629A (ja) 検体前処理方法
JP2684425B2 (ja) ラテックス試薬
JP3040224B2 (ja) 免疫学的凝集反応粒子の製造方法
JPS62168051A (ja) 凝集反応試験用水性溶媒
JPH0359382B2 (en, 2012)
JPS5931454A (ja) 赤血球凝集試験用水性溶媒
JP3487651B2 (ja) 免疫診断試薬の製造方法
JPH11183478A (ja) 抗体測定試薬及びその製造法
Pratumvinit et al. A Simple Plasminogen Determination by a Passive Hemagglutination–Inhibition Technic